Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: Phosphatidylinositol 3-kinase association to CD28 and cytokine production

被引:41
作者
GhiottoRagueneau, M
Battifora, M
Truneh, A
Waterfield, MD
Olive, D
机构
[1] INSERM,U119,F-13009 MARSEILLE,FRANCE
[2] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
[3] LUDWIG INST CANC RES,LONDON W1P 8BT,ENGLAND
关键词
phosphatidylinositol 3-kinase activity; B7.1/B7.2; human resting T cells;
D O I
10.1002/eji.1830260106
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 is a 44-kDa homodimer present on T cells providing an important costimulatory signal for T cell proliferation, cytokine production and cytokine receptor expression. CD28 activation is mediated by interaction with its counterreceptors, B7.1/CD80 and B7.2/B70/CD86. The biochemical basis of these costimulatory signals are still poorly understood, particularly in resting T cells. However, various biochemical pathways such as tyrosine phosphorylation, phospholipase C, sphingomyelinase and phosphatidylinositol 3-kinase (PI3-K) activation have been reported to play a role in CD28 signaling in tumor T cell lines and CD28-transfected cells or pre-activated T cells. In addition, recent reports propose that CD28-B7.1 and B7.2 interaction could be involved in the production of Th1 and Th2 cytokines, respectively, but the putative biochemical basis for these different functions is still unknown. We have analyzed the functional and molecular consequences of CD28 activation by B7.1 and B7.2 in human resting T cells. We demonstrate in this report that both CD28-B7.1 and CD28-B7.2 interactions induce the association of PI3-K to CD28 in the CD4 subpopulation, whereas it was barely detectable in CD8 cells. This association involves the binding of the src homology domain 2 (SH2) of p85 to tyrosine-phosphorylated CD28 and does not require pre-activation by CD3-T cell receptor. Worthmannin, a specific inhibitor of PI3-K enzymatic activity within the nanomolar range also inhibits the interleukin-2 production induced by co-stimulation mediated by either the B7.1- and B7.2-transfected cells or CD28 monoclonal antibodies. The only slight difference between B7.1 and B7.2 co-stimulation is the IC50 of wortmannin being 25 and 110 nM, respectively, which could suggest differences in their activation of the T cell PI3-K.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 68 条
  • [51] RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0
  • [52] CD28-B7 BLOCKADE AFTER ALLOANTIGENIC CHALLENGE IN-VIVO INHIBITS TH1 CYTOKINES BUT SPARES TH2
    SAYEGH, MH
    AKALIN, E
    HANCOCK, WW
    RUSSELL, ME
    CARPENTER, CB
    LINSLEY, PS
    TURKA, LA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) : 1869 - 1874
  • [53] T-CELL ANTIGEN CD28 BINDS TO THE GRB-2/SOS COMPLEX, REGULATORS OF P21(RAS)
    SCHNEIDER, H
    CAI, YC
    PRASAD, KVS
    SHOELSON, SE
    RUDD, CE
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) : 1044 - 1050
  • [54] SIEGEL JN, 1993, J IMMUNOL, V151, P4116
  • [55] THE CYTOPLASMIC DOMAIN OF CD28 IS BOTH NECESSARY AND SUFFICIENT FOR COSTIMULATION OF INTERLEUKIN-2 SECRETION AND ASSOCIATION WITH PHOSPHATIDYLINOSITOL 3'-KINASE
    STEIN, PH
    FRASER, JD
    WEISS, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3392 - 3402
  • [56] JNK IS INVOLVED IN SIGNAL INTEGRATION DURING COSTIMULATION OF T-LYMPHOCYTES
    SU, B
    JACINTO, E
    HIBI, M
    KALLUNKI, T
    KARIN, M
    BEN-NERIAH, Y
    [J]. CELL, 1994, 77 (05) : 727 - 736
  • [57] SUNG CK, 1994, J BIOL CHEM, V269, P12503
  • [58] CD28 ACTIVATION PATHWAY REGULATES THE PRODUCTION OF MULTIPLE T-CELL-DERIVED LYMPHOKINES CYTOKINES
    THOMPSON, CB
    LINDSTEN, T
    LEDBETTER, JA
    KUNKEL, SL
    YOUNG, HA
    EMERSON, SG
    LEIDEN, JM
    JUNE, CH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) : 1333 - 1337
  • [59] STIMULATION OF CD28 TRIGGERS AN ASSOCIATION BETWEEN CD28 AND PHOSPHATIDYLINOSITOL 3-KINASE IN JURKAT T-CELLS
    TRUITT, KE
    HICKS, CM
    IMBODEN, JB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) : 1071 - 1076
  • [60] UEDA YY, 1995, INT IMMUNOL, V10, P100